Senior Director - Discovery Sciences/Design and Synthesis Sciences, Pfizer
Adam M. Gilbert received his B.A. in chemistry from Haverford College and his Ph.D. in organic chemistry from Columbia University working with Professor Thomas Katz. After a postdoctoral fellowship with Professor William Wulff at the University of Chicago, he joined Medical Research Division of American Cyanamid in Pearl River, NY which quickly became Wyeth Research. At Wyeth, Adam worked across multiple therapeutic areas: metabolic diseases, antibacterials, neuroscience, oncology and inflammation. He was also responsible for managing the Exploratory Chemistry Neuroscience Hit to Lead portfolio which ultimately produced several successful development programs.
Adam joined Pfizer in Groton, CT in February 2010 as an Associate Research Fellow and a labhead in charge of the Experimental Design Chemistry – a group that focuses on key portfolio projects with challenging medicinal chemistry design issues including covalent inhibitors, allosteric GPCR modulators and chemoproteomics. His group helped successfully put multiple compounds into the clinic including PF-06651600, a selective JAK3 inhibitor currently in Ph III trials for Alopecia Areata.
Adam Gilbert is currently a Senior Director at Pfizer where he leads Design and Synthesis Sciences – a medicinal chemistry group which focuses on new modalities and technologies in design, synthesis, computational chemistry, DEL chemistry, molecular properties and small molecule purification. His group is driving Pfizer’s effort on protein degradation.